严重急性呼吸综合征冠状病毒2：病毒脱落与传染性的困境。
SARS-CoV-2: The viral shedding vs infectivity dilemma.
作者信息
Widders Arabella, Broom Alex, Broom Jennifer
机构信息
Department of Medicine, Sunshine Coast Hospital and Health Service, Birtinya, 4575, Queensland, Australia.
School of Social and Political Sciences, The University of Sydney, Sydney, 2006, New South Wales, Australia.
出版信息
Infect Dis Health. 2020 Aug;25(3):210-215. doi: 10.1016/j.idh.2020.05.002. Epub 2020 May 20.
Abstract
Since December 2019, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has infected over four million people worldwide. There are multiple reports of prolonged viral shedding in people infected with SARS-CoV-2 but the presence of viral RNA on a test does not necessarily correlate with infectivity. The duration of quarantine required after clinical recovery to definitively prevent transmission is therefore uncertain. In addition, asymptomatic and presymptomatic transmission may occur, and infectivity may be highest early after onset of symptoms, meaning that contact tracing, isolation of exposed individuals and social distancing are essential public health measures to prevent further spread. This review aimed to summarise the evidence around viral shedding vs infectivity of SARS-CoV-2.
摘要
自2019年12月以来，严重急性呼吸综合征冠状病毒2（SARS-CoV-2）已在全球感染了超过400万人。有多项报告指出，感染SARS-CoV-2的人存在病毒长期脱落的情况，但检测中病毒RNA的存在并不一定与传染性相关。因此，临床康复后确定预防传播所需的隔离时间尚不确定。此外，可能会发生无症状和症状出现前的传播，且传染性可能在症状出现后的早期最高，这意味着接触者追踪、对暴露个体的隔离以及社交距离措施是防止进一步传播的重要公共卫生措施。本综述旨在总结关于SARS-CoV-2病毒脱落与传染性的相关证据。
相似文献
1
SARS-CoV-2: The viral shedding vs infectivity dilemma.
Infect Dis Health. 2020 Aug;25(3):210-215. doi: 10.1016/j.idh.2020.05.002. Epub 2020 May 20.
2
The presence of SARS-CoV-2 RNA in the feces of COVID-19 patients.
J Med Virol. 2020 Jul;92(7):833-840. doi: 10.1002/jmv.25825. Epub 2020 Apr 25.
3
Environmental surface testing for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) during prolonged isolation of an asymptomatic carrier.
Infect Control Hosp Epidemiol. 2020 Nov;41(11):1328-1330. doi: 10.1017/ice.2020.300. Epub 2020 Jun 16.
4
Ocular Symptoms of SARS-CoV-2: Indication of Possible Ocular Transmission or Viral Shedding.
Ocul Immunol Inflamm. 2020 Nov 16;28(8):1269-1279. doi: 10.1080/09273948.2020.1799035. Epub 2020 Sep 1.
5
Virus shedding dynamics in asymptomatic and mildly symptomatic patients infected with SARS-CoV-2.
Clin Microbiol Infect. 2020 Nov;26(11):1556.e1-1556.e6. doi: 10.1016/j.cmi.2020.07.008. Epub 2020 Jul 9.
6
Factors Associated With Prolonged Viral RNA Shedding in Patients with Coronavirus Disease 2019 (COVID-19).
Clin Infect Dis. 2020 Jul 28;71(15):799-806. doi: 10.1093/cid/ciaa351.
7
A preliminary study on contact tracing & transmission chain in a cluster of 17 cases of severe acute respiratory syndrome coronavirus 2 infection in Basti, Uttar Pradesh, India.
Indian J Med Res. 2020;152(1 & 2):95-99. doi: 10.4103/ijmr.IJMR_2914_20.
8
Viral dynamics in asymptomatic patients with COVID-19.
Int J Infect Dis. 2020 Jul;96:288-290. doi: 10.1016/j.ijid.2020.05.030. Epub 2020 May 11.
9
SARS-CoV-2 detection, viral load and infectivity over the course of an infection.
J Infect. 2020 Sep;81(3):357-371. doi: 10.1016/j.jinf.2020.06.067. Epub 2020 Jun 29.
10
Clinical features of discharged COVID-19 patients with an extended SARS-CoV-2 RNA positive signal in respiratory samples.
Virus Res. 2020 Sep;286:198047. doi: 10.1016/j.virusres.2020.198047. Epub 2020 Jun 6.
引用本文的文献
1
A Modular Mathematical Model of the Immune Response for Investigating the Pathogenesis of Infectious Diseases.
Viruses. 2025 Apr 22;17(5):589. doi: 10.3390/v17050589.
2
A generalised catalytic model to assess changes in risk for multiple reinfections with SARS-CoV-2.
PLoS One. 2025 Jan 2;20(1):e0315476. doi: 10.1371/journal.pone.0315476. eCollection 2025.
3
Advancing COVID-19 diagnostics: rapid detection of intact SARS-CoV-2 using viability RT-PCR assay.
Microbiol Spectr. 2024 Sep 3;12(9):e0016024. doi: 10.1128/spectrum.00160-24. Epub 2024 Jul 22.
4
Microbiota, Viral Infection, and the Relationship to Human Diseases: An Area of Increasing Interest in the SARS-CoV-2 Pandemic.
Infect Microbes Dis. 2020 Nov 4;3(1):1-3. doi: 10.1097/IM9.0000000000000043. eCollection 2021 Mar.
5
Factors Associated With Prolonged Respiratory Virus Detection From Polymerase Chain Reaction of Nasal Specimens Collected Longitudinally in Healthy Children in a US Birth Cohort.
J Pediatric Infect Dis Soc. 2024 Mar 19;13(3):189-195. doi: 10.1093/jpids/piae009.
6
Assessing the efficacy and safety of Yinqiao powder-maxing Ganshi decoction in the treatment of the major symptoms of mild and moderate COVID-19 by telemedicine-study protocol for a randomized, double-blind, placebo-controlled trial.
Front Pharmacol. 2024 Jan 8;14:1261338. doi: 10.3389/fphar.2023.1261338. eCollection 2023.
7
Estimation of shedding time in laboratory-confirmed COVID-19 cases in South Africa: a population-based record linkage study, March-December 2020.
Pan Afr Med J. 2023 Sep 15;46:24. doi: 10.11604/pamj.2023.46.24.41047. eCollection 2023.
8
Non-Pharmacological Strategies and Interventions for Effective COVID-19 Control: A Narrative Review.
J Clin Med. 2023 Oct 11;12(20):6465. doi: 10.3390/jcm12206465.
9
Impact of SARS-CoV-2-Related Hygiene Measures on Community-Acquired Respiratory Virus Infections in Lung Transplant Recipients in Switzerland.
Medicina (Kaunas). 2023 Aug 16;59(8):1473. doi: 10.3390/medicina59081473.
10
Comparing SARS-CoV-2 Viral Load in Human Saliva to Oropharyngeal Swabs, Nasopharyngeal Swabs, and Sputum: A Systematic Review and Meta-Analysis.
Can J Infect Dis Med Microbiol. 2023 Aug 10;2023:5807370. doi: 10.1155/2023/5807370. eCollection 2023.
本文引用的文献
1
First confirmed detection of SARS-CoV-2 in untreated wastewater in Australia: A proof of concept for the wastewater surveillance of COVID-19 in the community.
Sci Total Environ. 2020 Aug 1;728:138764. doi: 10.1016/j.scitotenv.2020.138764. Epub 2020 Apr 18.
2
Connecting clusters of COVID-19: an epidemiological and serological investigation.
Lancet Infect Dis. 2020 Jul;20(7):809-815. doi: 10.1016/S1473-3099(20)30273-5. Epub 2020 Apr 21.
3
Presymptomatic SARS-CoV-2 Infections and Transmission in a Skilled Nursing Facility.
N Engl J Med. 2020 May 28;382(22):2081-2090. doi: 10.1056/NEJMoa2008457. Epub 2020 Apr 24.
4
Viral load dynamics and disease severity in patients infected with SARS-CoV-2 in Zhejiang province, China, January-March 2020: retrospective cohort study.
BMJ. 2020 Apr 21;369:m1443. doi: 10.1136/bmj.m1443.
5
Coronavirus Disease 2019 Pneumonia in Immunosuppressed Renal Transplant Recipients: A Summary of 10 Confirmed Cases in Wuhan, China.
Eur Urol. 2020 Jun;77(6):748-754. doi: 10.1016/j.eururo.2020.03.039. Epub 2020 Apr 18.
6
Duration of Viral Shedding of Discharged Patients With Severe COVID-19.
Clin Infect Dis. 2020 Nov 19;71(16):2240-2242. doi: 10.1093/cid/ciaa451.
7
Temporal dynamics in viral shedding and transmissibility of COVID-19.
Nat Med. 2020 May;26(5):672-675. doi: 10.1038/s41591-020-0869-5. Epub 2020 Apr 15.
8
Prolonged virus shedding even after seroconversion in a patient with COVID-19.
J Infect. 2020 Aug;81(2):318-356. doi: 10.1016/j.jinf.2020.03.063. Epub 2020 Apr 10.
9
Covid-19: four fifths of cases are asymptomatic, China figures indicate.
BMJ. 2020 Apr 2;369:m1375. doi: 10.1136/bmj.m1375.
10
Virological assessment of hospitalized patients with COVID-2019.
Nature. 2020 May;581(7809):465-469. doi: 10.1038/s41586-020-2196-x. Epub 2020 Apr 1.
Zotero 插件